Associate Scientist 1
Pliant Therapeutics
Associate Scientist 1
Pliant Therapeutics
Develops integrin-targeted therapies for fibrosis
At Pliant, we believe differentiated science can make a meaningful impact. We see our success as a direct result of the central role that each team member plays in advancing our mission to develop therapies that target the disease at its source. We are seeking creative, curious and collaborative individuals who dare to succeed, are committed to making an important impact on patient’s lives and will help us build one Pliant!
We are seeking an Associate Scientist I to develop, optimize and run biochemical binding assays that screen compounds in medium- to high-throughput format. You will own AlphaScreen/AlphaLISA assays from reagent qualification through routine screening, generating the potency and selectivity data that drive our medicinal chemistry decisions. This is a hands-on laboratory role reporting to Senior Vice President, Research based in South San Francisco.
To perform this job successfully, an individual must be able to perform each essential duty. The requirements listed below are representative of the knowledge, skill, abilities, and prior experience required.
Required Qualifications
The annual base salary for this role is $125K – $138K. Individual pay may vary based on additional factors, including, and without limitation job-related skills, experience, work location and relevant education or training. Pliant’s compensation package also includes benefits, equity, and annual target bonus for fulltime positions.
To understand how Pliant complies with and manages your personal information with respect to the California Consumer Privacy Act, please visit https://pliantrx.com/ccpa-applicant-and-staff-privacy-notice/.
Develops integrin-targeted therapies for fibrosis
Pliant Therapeutics develops drugs to treat fibrotic diseases. The company focuses on inhibiting integrin pathways involved in tissue scarring to stop disease progression and potentially restore normal organ function. Its products work by targeting fibrosis-related mechanisms at the molecular level, guided by medicinal chemistry and advanced screening technologies, and advancing candidates through clinical trials toward commercialization. Pliant differentiates itself through deep expertise in integrin biology and fibrosis, aiming to create best-in-class therapies that can address multiple fibrotic indications and provide targeted, effective treatments. The company’s goal is to transform the treatment of fibrotic diseases by halting progression and reversing fibrosis, improving patient outcomes and organ function.
Explore more opportunities at Pliant Therapeutics